ELAVL1 and breast carcinoma: The highly deregulated pattern of TTP–HuR expression, both in cell lines and in patient samples, prompted us to investigate whether HuR mRNA itself is a target for TTP-mediated mRNA decay and whether TTP deficiency in breast cancer is causative for HuR over-expression.